HCA Holdings (HCA) PT Lowered to $92 at Mizuho Securities; Reiterates Buy
Mizuho Securities lowered its price target on HCA Holdings (NYSE: HCA) to $92.00 (from $98.00) while maintaining a Buy rating. Analyst Sheryl Skolnick still believes that HCA can still preserve margin in 2018, can still grow the top line and can generate around 4% EBITDA growth.
Mizuho is worried about the future for HCA, but is less worried than if the company didn’t have CFFO and FCF to deploy for growth, investment and share repurchases.